Scan Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -62.94%
- Profit Growth -160.34%
- Ebitda -624.13%
- Net Worth -17.93%
- Total Assets -44.06%
About Scan Biotech
Scan Biotech Limited (SBL) is a Public Limited Indian Non-Government Company incorporated in India on 23 April 2004 and has a history of 20 years and ten months. Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jyotika Shrivastava, Salil Shrivastava, and Rajan Dubey serve as directors at the Company.
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02411MP2004PLC016576
- Company No.
016576
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Scan Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotika Shrivastava  | Director | 23-Apr-2004 | Current |
| Salil Shrivastava | Director | 23-Apr-2004 | Current |
| Rajan Dubey | Director | 23-Jan-2013 | Current |
Financial Performance of Scan Biotech.
Scan Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.94% decrease. The company also saw a substantial fall in profitability, with a 160.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scan Biotech?
In 2022, Scan Biotech had a promoter holding of 97.00% and a public holding of 3.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Duti Agri Associates Private LimitedRajan Dubey is a mutual person
- Mahakaushal Sugar And Power Industries Limited
Rajan Dubey is a mutual person
- Narsinghpur Animal Welfare Product And Services Private Limited
Rajan Dubey is a mutual person
- Dojcan & Dubey Private Limited
Rajan Dubey is a mutual person
- Srs Unistraw Private Limited
Rajan Dubey is a mutual person
- Clesstra Healthcare Private Limited
Rajan Dubey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Scan Biotech?
Unlock and access historical data on people associated with Scan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
